www.fdanews.com/articles/74095-vioquest-agrees-to-acquire-greenwich
VIOQUEST AGREES TO ACQUIRE GREENWICH
July 8, 2005
VioQuest Pharmaceuticals, a biopharmaceutical company focused on acquiring, developing and commercializing novel compounds with broad therapeutic applications, entered into a definitive merger agreement to acquire Greenwich Therapeutics, which owns exclusive license rights to two anti-cancer agents -- sodium stibogluconate (SSG) and triciribine (TCN-P).
Pharmalive (http://www.medadnews.com/News/Index.cfm?articleid=254647)